Dogwood Therapeutics Inc.
DWTX
We are a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. Following the closing of the Combination described below, we became the sole owner of Pharmagesic (Holdings) Inc. ( Pharmagesic ) and their wholly owned subsidiary, Wex Pharmaceuticals, Inc. ( Wex ), and Wex's wholly owned subsidiaries, IWT Bio, Inc. ( …
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$25M
▼ -177.4% YoY
Op. Margin
–
ROIC
-30.51%
▲ +422.9pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$16M
▼ -77.7% YoY
Net Debt
-$5M
Net Cash Position
Cash & Equiv.
$5M
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with DWTX
Dogwood Therapeutics (DWTX) in two numbers
Questions about Dogwood Therapeutics
Is Dogwood Therapeutics (DWTX) overvalued?
Dogwood Therapeutics trades at 0.10 times earnings. Intrinsiqq's fair value calculator has no opening value for DWTX, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.
Does Dogwood Therapeutics (DWTX) pay a dividend?
No. Dogwood Therapeutics (DWTX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 3 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in DWTX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing DWTX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.